IncFact
Company Profiles: Revenue, Growth, Competition

RUBIUS THERAPEUTICS Revenue, Growth & Competitor Profile

Last updated:

Company Awards

VC / Private Equity
Venture Capital / Private Equity
Fast Growing
Fastest Growing
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Rubius Therapeutics

Access the complete profile.

Rubius Therapeutics Fast Facts

Revenue$100 - $500 million    See Exact Annual Revenue
EmployeesN/AExact Company Size
Primary Industry3254 Pharmaceutical & Medicine Manufacturing
Address124 Washington St
Suite 101
Foxborough, MA 02035

rubiustx.com
Note: Revenues for privately held companies are statistical evaluations.


Rubius Therapeutics's annual revenues are $100-$500 million (see exact revenue data). It is classified as operating in the Pharmaceutical & Medicine Manufacturing industry.


Rubius Therapeutics's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Rubius Therapeutics Annual Revenue and Growth Rate

Rubius Therapeutics Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Rubius Therapeutics's revenues are gauged from an analysis of company filings.



Investor Activity

Rubius Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
March 1, 2018 27 100%$101 MM
Complete list of funding rounds and total amounts in the Company Report




Rubius Therapeutics's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Rubius Therapeutics Revenue (Sales) Rubius Therapeutics Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Rubius Therapeutics is developing and marketing. Rubius Therapeutics doesn't have any recent trademark applications, indicating Rubius Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
REALIZING THE POWER OF RED
Cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, and other diseases and disorders; pharmaceutical preparations of cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, and other diseases and disorders, namely, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders
02/14/2019
RTX
Cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, and other diseases and disorders, namely, central nervous system diseases and disorders, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders
08/07/2018
RUBIUS THERAPEUTICS
cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, and other diseases and disorders, namely, central nervous system diseases and disorders, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders
01/03/2017

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Rubius Therapeutics grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Rubius Therapeutics is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Pharmaceutical & Medicine Manufacturing

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Rubius Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Rubius Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
PFIZERNew York, NY100 
ABBOTT LABORATORIESAbbott Park, IL91 
BRISTOL-MYERS SQUIBBPrinceton, NJ86 
MERCK SHARP & DOHMERahway, NJ66 
ELI LILLYIndianapolis, IN65 
CSL BEHRINGKing Of Prussia, PA64 
CSLB HOLDINGSKing Of Prussia, PA63 
MERCKRahway, NJ62 
ALLERGANChicago, IL61 




Nearby Competitors

These companies are similar in business line and location to Rubius Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
RUBIUS THERAPEUTICSFoxborough, MA100 
KALEIDO BIOSCIENCESFoxborough, MA21 
APTINYXFoxborough, MA8 
CORBUS PHARMACEUTICALSNorwood, MA7 
KINASET THERAPEUTICSMedfield, MA0 




Future Competition: Rubius Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Rubius Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Rubius Therapeutics Competitors